Abstract
In this issue of Blood, Turesson et al study the risk of progression of monoclonal gammopathy of undetermined significance (MGUS) to lymphoplasma cellular and myeloid malignancies in a large population, validating current risk factors and adding immunoparesis as a predictor of progression.
| Original language | English |
|---|---|
| Pages (from-to) | 305-307 |
| Number of pages | 3 |
| Journal | Blood |
| Volume | 123 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jan 16 2014 |
ASJC Scopus subject areas
- Hematology
- Biochemistry
- Cell Biology
- Immunology